Annual EBITDA
$2.20B$159.40M+7.82%
Summary
- Current Value
- As of today, LH annual EBITDA is $2.20B, up +7.82% on
- Historical Performance
- LH annual EBITDA is down -4.02% over the past 3 years, down -42.09% over the past 5 years
- All-Time High Comparison
- LH annual EBITDA is currently -48.91% below its historical high of $4.30B set on
- 3-Year Low Comparison
- LH annual EBITDA is +28.90% above its 3-year low of $1.70B reached on
- Sector Comparison
- LH annual EBITDA is higher than 95.74% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.20B | +7.8% | -4.0% | -42.1% | +80.4% | |
| Quarterly EBITDA | $555.00M | +38.3% | +6.9% | -63.9% | +81.8% | |
| TTM EBITDA | $2.20B | +23.3% | -15.5% | -40.3% | +80.1% | |
| Price | $281.21 | +9.5% | +36.8% | +39.4% | +254.3% | |
| PE Ratio | 26.89 | -7.5% | +81.1% | +110.9% | +79.9% | |
| Annual Revenue | $13.95B | +7.3% | +17.6% | -0.2% | +178.8% | |
| Annual EPS | $10.46 | +18.3% | -25.1% | -34.1% | +97.5% | |
| $1.52B | +33.2% | -13.5% | -48.9% | +49.2% | ||
| Annual Net Income | $877.70M | +17.5% | -12.5% | -43.6% | +53.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.29B | N/A | -4.0% |
| 5Y | $4.30B | -48.9% | |
| All | $4.30B | -48.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.70B | +28.9% | |
| 5Y | $1.70B | +28.9% | |
| All | $17.50M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of LH?
As of today, LH annual EBITDA is $2.20B
What is 1-year change in LH annual EBITDA?
LH annual EBITDA is up +7.82% year-over-year
What is 3-year change in LH annual EBITDA?
LH annual EBITDA is down -4.02% over the past 3 years
How far is LH annual EBITDA from its all-time high?
LH annual EBITDA is currently -48.91% below its historical high of $4.30B set on December 31, 2021
How does LH annual EBITDA rank versus sector peers?
LH annual EBITDA is higher than 95.74% of companies in Healthcare sector
When is LH next annual earnings release?
As of today, the next annual earnings release for LH has not been scheduled
Quarterly EBITDA
$555.00M$19.20M-3.34%
Summary
- Current Value
- As of today, LH quarterly EBITDA is $555.00M, down -3.34% on
- Historical Performance
- LH quarterly EBITDA is up +38.30% year-over-year, up +6.92% over the past 3 years
- All-Time High Comparison
- LH quarterly EBITDA is currently -63.91% below its historical high of $1.54B set on
- 3-Year Low Comparison
- LH quarterly EBITDA is +46.32% above its 3-year low of $379.30M reached on
- Sector Comparison
- LH quarterly EBITDA is higher than 95.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $555.00M | -3.3% | +38.3% | +6.9% | -63.9% | |
| Annual EBITDA | $2.20B | – | +7.8% | -4.0% | -42.1% | |
| TTM EBITDA | $2.20B | +7.5% | +23.3% | -15.5% | -40.3% | |
| Price | $281.21 | +7.5% | +9.5% | +36.8% | +39.4% | |
| PE Ratio | 26.89 | +4.7% | -7.5% | +81.1% | +110.9% | |
| Quarterly Revenue | $3.52B | -1.3% | +5.6% | -4.3% | -21.7% | |
| Quarterly EPS | $1.98 | -36.5% | +16.2% | +131.5% | -79.3% | |
| $382.00M | -5.3% | +65.6% | +2.5% | -70.7% | ||
| Quarterly Net Income | $164.90M | -36.9% | +14.8% | +115.8% | -82.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $574.20M | -3.3% | |
| 3Y | $574.20M | -3.3% | |
| 5Y | $1.54B | N/A | -63.9% |
| All | $1.54B | -63.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $401.30M | N/A | +38.3% |
| 3Y | $379.30M | +46.3% | |
| 5Y | $379.30M | +46.3% | |
| All | -$132.70M | +518.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of LH?
As of today, LH quarterly EBITDA is $555.00M
What is LH quarterly EBITDA most recent change?
LH quarterly EBITDA was down -3.34% on December 31, 2025
What is 1-year change in LH quarterly EBITDA?
LH quarterly EBITDA is up +38.30% year-over-year
How far is LH quarterly EBITDA from its all-time high?
LH quarterly EBITDA is currently -63.91% below its historical high of $1.54B set on December 31, 2020
How does LH quarterly EBITDA rank versus sector peers?
LH quarterly EBITDA is higher than 95.71% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
TTM EBITDA
$2.20B$153.70M+7.52%
Summary
- Current Value
- As of today, LH TTM EBITDA is $2.20B, up +7.52% on
- Historical Performance
- LH TTM EBITDA is up +23.34% year-over-year, down -15.52% over the past 3 years
- All-Time High Comparison
- LH TTM EBITDA is currently -56.68% below its historical high of $5.07B set on
- 3-Year Low Comparison
- LH TTM EBITDA is +24.88% above its 3-year low of $1.76B reached on
- Sector Comparison
- LH TTM EBITDA is higher than 95.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.20B | +7.5% | +23.3% | -15.5% | -40.3% | |
| Annual EBITDA | $2.20B | – | +7.8% | -4.0% | -42.1% | |
| Quarterly EBITDA | $555.00M | -3.3% | +38.3% | +6.9% | -63.9% | |
| Price | $281.21 | +7.5% | +9.5% | +36.8% | +39.4% | |
| PE Ratio | 26.89 | +4.7% | -7.5% | +81.1% | +110.9% | |
| TTM Revenue | $13.95B | +1.4% | +7.3% | +4.4% | -0.2% | |
| TTM EPS | $10.46 | +2.7% | +18.4% | -24.4% | -33.9% | |
| $1.52B | +11.1% | +33.2% | -21.0% | -48.7% | ||
| TTM Net Income | $877.70M | +2.5% | +17.5% | -21.2% | -43.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.20B | at high | |
| 3Y | $2.60B | N/A | -15.5% |
| 5Y | $5.07B | -56.7% | |
| All | $5.07B | -56.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.78B | N/A | +23.3% |
| 3Y | $1.76B | +24.9% | |
| 5Y | $1.76B | +24.9% | |
| All | $17.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of LH?
As of today, LH TTM EBITDA is $2.20B
What is LH TTM EBITDA most recent change?
LH TTM EBITDA was up +7.52% on December 31, 2025
What is 1-year change in LH TTM EBITDA?
LH TTM EBITDA is up +23.34% year-over-year
How far is LH TTM EBITDA from its all-time high?
LH TTM EBITDA is currently -56.68% below its historical high of $5.07B set on June 30, 2021
How does LH TTM EBITDA rank versus sector peers?
LH TTM EBITDA is higher than 95.80% of companies in Healthcare sector
When is LH next earnings release?
The next earnings release for LH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- LH Official Website www.labcorp.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/920148/000092014826000017/0000920148-26-000017-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/920148/000092014826000111/0000920148-26-000111-index.htm
- LH Profile on Yahoo Finance finance.yahoo.com/quote/LH
- LH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lh